When: Active Now
Where: Be Well Clinical Studies
Location: North Platte, Nebraska and Round Rock, Texas
You may qualify for this study if:
you are an adult with type 1 diabetes who has received insulin treatment
Do you have type 1 diabetes?
This study will investigate how well insulin icodec (a new, investigational long-acting insulin taken once weekly), controls blood sugar in people with diabetes. Once-weekly insulin icodec will be compared with insulins taken once daily, which are already available on the market.
As part of the program, this study will look at how well insulin icodec taken once weekly and insulin glargine U100 taken once daily control blood sugar in combination with insulin aspart, in adults with type 1 diabetes over a period of about 8.5 months.
This could be your chance to:
Take a more active role in managing your diabetes
Get regular expert medical care
Help others by contributing to medical research